GlassScriptPhysician profile
Anthony H Ibay
NPI 1154498418
$1,450.89
in general payments reported to CMS, 2019-2025
21 companies · $85.93 in 2025
The $85.93 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $171 · 2021: $325 · 2022: $278 · 2023: $142 · 2024: $258 · 2025: $85.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $390 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $390.29 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $275.79 | 2020-2024 | |
| Therapeuticsmd, INC. | $228.26 | 2020-2022 | |
| Astellas Pharma US INC | $157.62 | 2023-2024 | Veozah |
| Hologic Sales and Service, LLC | $147.68 | 2020-2025 | Aptima, Thinprep 2000 Processor |
| Sage Therapeutics, LLC | $108.51 | 2024-2025 | Zurzuvae |
| Mylan Pharmaceuticals INC. | $60.00 | 2021 | |
| Mayne Pharma Commercial LLC | $50.94 | 2022-2023 | |
| Roche Diagnostics Corporation | $50.23 | 2019 | |
| Organon LLC | $43.59 | 2023-2024 | Nexplanon |
| Exeltis, USA INC. | $42.57 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $41.62 | 2021-2022 | |
| Pfizer INC. | $36.05 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.59 | 2021 | |
| Myovant Sciences INC. | $32.13 | 2021-2022 | |
| Avion Pharmaceuticals | $27.21 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $24.39 | 2019 | |
| Agile Therapeutics, INC. | $21.49 | 2023 | Twirla |
| Mission Pharmacal Company | $19.98 | 2019 | |
| Avanos Medical | $17.57 | 2019 | |
| Daiichi Sankyo INC. | $15.56 | 2019 | |
| Amag Pharmaceuticals, INC. | $15.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Ibay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.